CSL PLASMA
Live / Applied — Fourth extension granted (statement of use) (as of 27 Jan 2026)
What this means for you
Not registered yet, but its 04 Oct 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97618260
- Mark type
- Stylized text
- Filed
- 04 Oct 2022
- Published for opposition
- 02 Jan 2024
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 035 — Advertising and business services: Promoting public awareness of blood diseases, illnesses and conditions; promoting awareness of vaccines and related illnesses; Promoting public awareness of blood plasma donation; Promoting the donation of blood and volunteer services and financial resources in the field of blood donations by means of arranging and conducting incentive reward programs; Providing information regarding medical billing support services, namely, medical records coding services for others in the nature of assignment of diagnostic and procedural codes for purposes of reimbursement from insurance
- Class 036 — Insurance and financial services: Insurance information and consultancy; charitable services, namely, providing financial support and financial information to patients and caregivers for obtaining medications, medical treatment, and access to care; Providing insurance information for patients diagnosed with medical conditions regarding medication access and reimbursement programs and insurance premium and co-pay assistance; providing insurance consulting services to patients diagnosed with medical conditions regarding obtaining approval, authorization, and verification of insurance coverage for treatment, determining existing insurance benefits, and appealing from denial of insurance coverage and acquiring letters of medical necessity for insurance coverage; providing financial assistance programs to appropriate patients
- Class 040 — Treatment of materials: Treatment of biological products, namely, custom manufacturing and fractionation of blood; Processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; production of reagents for immunohaematology laboratories for scientific or medical research use; processing of human blood plasma, namely, removing whole blood and separating red blood cells from plasma; treatment of human blood and plasma; custom manufacturing of human blood and plasma
- Class 041 — Education and entertainment services: Education services, namely, providing classes, seminars, and workshops in the field of continuing medical education and health education; Education services, namely, providing classes, seminars, and workshops in the field of blood plasma, donation of blood plasma and blood plasma conditions; Educational services, namely, providing online instruction in the field of health, medicine, pharmaceuticals and medical treatment via an online website; Educational services, namely, providing online instruction in the field of blood plasma and blood plasma conditions via an online website; Non-downloadable electronic publications, namely, newsletters in the field of health, medicine, pharmaceuticals and treatment; Non-downloadable electronic publications, namely, newsletters in the field of blood plasma and blood plasma conditions
- Class 042 — Scientific and technological services: Medical Research; Scientific Research in the field of medicines; Scientific Research and Development in the field of medicines; research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceutical preparations for gene therapy; Scientific Research in the field of blood plasma and blood plasma donation; Research and Development services in the fields of medicine, healthcare, blood conditions, gene and cell therapy, biotherapies and vaccines; Scientific and technological research, namely, scientific testing and screening services, in the nature of testing of human blood plasma for safety and quality; research and development of medical products, pharmaceutical products and blood products; new product research and development services; Laboratory analysis, namely, medical laboratory services and scientific laboratory services; Laboratory research services relating to pharmaceuticals and blood plasma; scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma; Providing medical and scientific research information in the field of pharmaceuticals and blood plasma; Providing scientific information in the field of health care developments, blood plasma conditions, and new medical therapies; scientific information services in the field of health care developments, blood plasma conditions, and new medical therapies provided via the Internet; providing research information on donation of human blood for medical research
Owner
- CSL Limited, Parkville, Victoria, AU
- CSL Limited, Parkville, Victoria, AU
Prosecution history
- 30 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2026 — SOU EXTENSION 4 GRANTED
- 27 Jan 2026 — SOU EXTENSION 4 FILED
- 27 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2025 — SOU EXTENSION 3 GRANTED
- 28 Jul 2025 — SOU EXTENSION 3 FILED
- 28 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2025 — SOU EXTENSION 2 GRANTED
- 27 Jan 2025 — SOU EXTENSION 2 FILED
- 27 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jul 2024 — SOU EXTENSION 1 GRANTED
- 29 Jul 2024 — SOU EXTENSION 1 FILED